Sign in with Google
bullish
Shenzhen Hepalink (海瑞普) A+H: A Heparin-API King but Nothing Too Exciting
525 Views19 Feb 2020 08:25
Shenzhen Hepalink is seeking an up to USD 500 million in an A+H listing.The company is a dominant heparin supplier on a global scale but it is not...
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 8-minute read)
Related Insights
More »Loading
Trending Collections
More »Trending Insights
More »- CSI Hong Kong Connect Internet Index Rebalance: 10 Changes & Big Impact
- Horizon Robotics Placement - Momentum Is Strong but Raising Seems Opportunistic
- Foshan Haitian Flavouring (3288 HK) IPO: The Valuation Perspective
- Toyota Industries (6201 JP): Thoughts on Intrinsic Value
- S&P500 June 2025 Review Forecast: Weak but Interactive, Time for Duolingo?
Top Unpaywalled Insights
More »- Bearishness Persist in Soybeans Despite Rebound Hopes
- Curator's Cut: The Next Labubu, Crypto Equities and Tracking APAC Buybacks
- [IO Technicals 2025/23] Bearish Momentum Persists
- VEON US: Pakistan Towers Sale Frees Capital for Digital Growth in Core Market Ahead of Ukraine IPO
- Advanced Look: Navigating the New Macro Landscape Through Quantitative Alpha Generation Strategies
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
x